New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 18, 2014
10:47 EDTZMHZimmer advances following analyst upgrade
Shares of orthopedic device maker Zimmer (ZMH) are climbing after research firm William Blair upgraded the stock in a note to investors earlier today. WHAT'S NEW: William Blair analyst Matthew O'Brien is confident that Zimmer's proposed acquisition of another company in the sector, Biomet, will be approved by regulators, he wrote in a note to investors today. Moreover, he believes that the cost savings from the deal will be at least in-line with the targets set by Zimmer, generating significant accretion for the company. Noting that Zimmer's stock had retreated since the deal was announced, O'Brien wrote that the shares had reached an attractive entry point. He upgraded the stock to Outperform from Market Perform. WHAT'S NOTABLE: On July 28, research firm Oppenheimer upgraded Zimmer to Outperform from Perform, as the firm predicted that the company's acquisition of Biomet would help it generate strong earnings growth beginning next year. PRICE ACTION: In mid-morning trading, Zimmer rose 1.6% to $99.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
11:25 EDTZMHStryker, Smith & Nephew rise after reports of renewed bid
Subscribe for More Information
November 20, 2014
10:33 EDTZMHHigh option volume stocks
High option volume stocks: KBR LM PRGO CHRW DG ZMH LGF ZTS OSIR REGI
November 19, 2014
09:11 EDTZMHZimmer reports Synovasure PJI test earns certification
Subscribe for More Information
November 18, 2014
07:30 EDTZMHZimmer agrees with EC to extend deal review deadline by 'limited number of days'
Zimmer Holdings announced that it has agreed with the European Commission to extend the deadline for the EC's review of Zimmer's proposed acquisition of Biomet by a "limited number of days" in order to provide the EC with certain additional information. Under the previous timeline, the EC had until March 11, 2015 to make a final decision on the proposed transaction. As a result of this extension, the deadline for the EC's final decision will be extended by the limited amount of additional time that Zimmer has agreed to provide to the EC. "Deadline extensions are not uncommon in such in-depth investigations. Zimmer has been working closely with the regulatory authorities to facilitate their review of the pending transaction and is encouraged by the substantial progress that has been made to date in connection with the overall regulatory process. Zimmer continues to expect to close the transaction in the first quarter of 2015," the company said.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use